Jeito Capital exits biotech company HI-Bio for $1.15bn

Jeito Capital exits biotech company HI-Bio for $1.15bn

Paris-based private equity firm Jeito Capital will sell its portfolio company HI-Bio, a clinical-stage biotech company focused on immune-mediated diseases, to Biogen for $1.15bn.  The deal includes up to $650m in potential payments contingent on milestones being...
Hg to acquire risk platform AuditBoard for $3bn

Hg to acquire risk platform AuditBoard for $3bn

London-based private equity giant Hg has agreed to acquire AuditBoard, a cloud-based platform for audit, risk, compliance and ESG management, in a transaction valued at over $3bn including debt. The acquisition is being led by Hg’s San Francisco-based office, which...